CoChat

Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.

Collins, Curtis D, Brockhaus, Kara, Sim, Taeyong, Suneja, Anupam, Malani, Anurag N · 2019 · American Journal of Health-System Pharmacy

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Purpose: Results of a study incorporating real-world results into a predictive model to assess the cost-effectiveness of procalcitonin (PCT)-guided antibiotic use in intensive care unit patients with sepsis are reported. Methods: A single-center, retrospective cross-sectional study was conducted to determine whether reductions in antibiotic therapy duration and other care improvements resulting from PCT testing and use of an associated treatment pathway offset the costs of PCT testing. Selected base-case cost outcomes in adults with sepsis admitted to a medical intensive care unit (MICU) were assessed in preintervention and postintervention cohorts using a decision analytic model. Cost-minimization and cost–utility analyses were performed from the hospital perspective with a 1-year time horizon. Secondary and univariate sensitivity analyses tested a variety of clinically relevant scenarios and the robustness of the model. Results: Base-case modeling predicted that use of a PCT-guided treatment algorithm would results in hospital cost savings of $45 per patient and result in a gain of 0.0001 quality-adjusted life-year. After exclusion of patients in the postintervention cohort for PCT test ordering outside of institutional guidelines, the mean inpatient antibiotic therapy duration was significantly reduced in the postintervention group relative to the preintervention group (6.2 days versus 4.9 days, p = 0.04) after adjustment for patient sex and age, Charlson Comorbidity Index score, study period, vasopressor use, and ventilator use. Total annual hospital cost savings of $4,840 were predicted. Conclusion: Real-world implementation of PCT-guided antibiotic use may have improved patients’ quality of life while decreasing hospital costs in MICU patients with undifferentiated sepsis.

Overview

Integrity signals

Registry

Crossref · 10.1093/ajhp/zxz129

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 1

  1. Sim T , BrockhausK, CollinsCDet al Impact of procalcitonin (PCT) on antimicrobial use in intensive care unit patients at a community hospital. Abstract presented at Society for Healthcare Epidemiology of America (SHEA) Spring 2016 Conference: Science Guiding Prevention. Atlanta, GA; 2016 May 18-21.

Cited by

See all 25

Metadata

Authors
Collins, C. D., Brockhaus, K., Sim, T., Suneja, A., & Malani, A. N.
Affiliations
Trinity Health Michigan (US)
Corresponding author
Collins, Curtis D
Venue
American Journal of Health-System Pharmacy
Published
2019-08-01
Volume
76
Issue
16
Pages
1219-1225
ISSN
  • 1079-2082 (ISSN-L)
  • 1535-2900
OpenAlex
W2966723797
Cited by
25
References
11
Citations by year
2025: 3 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 2 · 2019: 1
FWCI
2.69
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Health-System Pharmacy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
procalcitonin, sepsis, antibiotic stewardship, cost-effectiveness, intensive care unit, antibiotic duration, bacterial infection, quality-adjusted life years, hospital costs, decision-analytic model, real-world implementation
MeSH terms
Procalcitonin, Aged, Anti-Bacterial Agents, Bacterial Infections, Cost-Benefit Analysis, Cross-Sectional Studies, Female, Health Plan Implementation, Humans, Intensive Care Units, Male, Middle Aged, Retrospective Studies, Program Evaluation, Biomarkers, Drug Costs, Drug Monitoring, Cost Savings, Hospital Mortality, Hospital Costs, Models, Economic, Sepsis, Quality-Adjusted Life Years, Critical Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis. https://app.cochat.ai/papers/10.1093/ajhp/zxz129
The paper
Collins, C. D., Brockhaus, K., Sim, T., Suneja, A., & Malani, A. N. (2019). Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxz129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.